These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 20198391)

  • 21. [Diabetes, obesity and heart complications].
    Picard F; dos Santos P; Catargi B
    Rev Prat; 2013 Jun; 63(6):759-64. PubMed ID: 23923748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.
    Pan KL; Hsu YC; Chang ST; Chung CM; Lin CL
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic cardiomyopathy--a distinct disease?
    Khavandi K; Khavandi A; Asghar O; Greenstein A; Withers S; Heagerty AM; Malik RA
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):347-60. PubMed ID: 19520308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R; Mogyorósi A; Ziyadeh FN
    Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy.
    Lebeche D; Davidoff AJ; Hajjar RJ
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):715-24. PubMed ID: 18813212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The heart and diabetes mellitus].
    Lerman Garber I; Ahumada Ayala M; Posadas Romero C
    Arch Inst Cardiol Mex; 1990; 60(1):79-88. PubMed ID: 2188626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
    Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
    Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities suggestive of cardiomyopathy in patients with type 2 diabetes of relatively short duration.
    Robillon JF; Sadoul JL; Jullien D; Morand P; Freychet P
    Diabete Metab; 1994; 20(5):473-80. PubMed ID: 7859895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.
    Farhangkhoee H; Khan ZA; Kaur H; Xin X; Chen S; Chakrabarti S
    Pharmacol Ther; 2006 Aug; 111(2):384-99. PubMed ID: 16343639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetic cardiomyopathy: old disease or new entity?].
    Seferović PM; Lalić NM; Seferović JP; Jotić A; Lalić K; Ristić AD; Simeunović D; Radovanović G; Vujisić-Tesić B; Ostajić MU
    Srp Arh Celok Lek; 2007; 135(9-10):576-82. PubMed ID: 18088046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with autonomic nervous function in type 1 and type 2 diabetic subjects free of clinical manifestations of autonomic neuropathy.
    Buscemi S; Blunda G; Maneri R; Di Maggio O; Cataldo MG; Brancato D; Verga S
    Ann Ital Med Int; 1998; 13(4):200-4. PubMed ID: 10349201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-ischemic diabetic cardiomyopathy may initially exhibit a transient subclinical phase of hyperdynamic myocardial performance.
    Hensel KO
    Med Hypotheses; 2016 Sep; 94():7-10. PubMed ID: 27515189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on diabetic cardiomyopathy: inches forward, miles to go.
    Tillquist MN; Maddox TM
    Curr Diab Rep; 2012 Jun; 12(3):305-13. PubMed ID: 22528596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in ion channel physiology in diabetic cardiomyopathy.
    Cesario DA; Brar R; Shivkumar K
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):601-10, ix-x. PubMed ID: 16959588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for heart disease in diabetic subjects.
    Fang ZY; Schull-Meade R; Leano R; Mottram PM; Prins JB; Marwick TH
    Am Heart J; 2005 Feb; 149(2):349-54. PubMed ID: 15846276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetic cardiomyopathy].
    Cohen A
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4):479-86. PubMed ID: 7646266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic cardiomyopathy--fact or fiction?
    Maisch B; Alter P; Pankuweit S
    Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus.
    Somaratne JB; Whalley GA; Bagg W; Doughty RN
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):109-25. PubMed ID: 18095911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice.
    Wang Y; Ebermann L; Sterner-Kock A; Wika S; Schultheiss HP; Dörner A; Walther T
    Exp Physiol; 2009 Feb; 94(2):220-7. PubMed ID: 18945756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.